
$INSILICO(03696.HK)
$XTALPI(02228.HK)
Stop hyping XtalPi, it's far behind compared to Insilico! Insilico Medicine is the true king of the AI world, with solid technology, explosive performance, and global recognition. Saying it's ten thousand times better than XtalPi is an understatement! From generative AI algorithms to clinical transformation, from oncology and chronic diseases to new agricultural materials, it has a fully integrated pipeline and leads in all scenarios. XtalPi still relies on a single massive order to save face, with its top five customers accounting for over 60% (highly concentrated), and its losses after deducting non-recurring items are staggering. Insilico has already broken the global AI drug discovery record with $2.75 billion, holds top clients like Pfizer and Sanofi, and real profitability is just a matter of time. Who is the real leader and who is just painting a rosy picture is crystal clear! Insilico is the best, the King of AI, well-deserved.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
